scholarly journals Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial

2021 ◽  
Author(s):  
Siobhan Hoscheidt ◽  
Ashley H. Sanderlin ◽  
Laura D. Baker ◽  
Youngkyoo Jung ◽  
Samuel Lockhart ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Randomized Trial ◽  
Cerebral Perfusion ◽  
Western Diet ◽  
Disease Biomarkers

P3-019: THE EFFECTS OF DIET INTERVENTION ON METABOLIC HEALTH AND CEREBRAL SPINAL FLUID ALZHEIMER'S DISEASE BIOMARKERS: A RANDOMIZED TRIAL

2006 ◽  
Vol 14 (7S_Part_19) ◽  
pp. P1069-P1070
Author(s):  
Ashley H. Sanderlin ◽  
Siobhan M. Hoscheidt ◽  
Angela J. Hanson ◽  
Laura D. Baker ◽  
Kaycee M. Sink ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Randomized Trial ◽  
Cerebral Spinal Fluid ◽  
Metabolic Health ◽  
Spinal Fluid ◽  
Disease Biomarkers ◽  
Diet Intervention

scholarly journals Association of CSF Alzheimer's disease biomarkers with postoperative delirium in older adults

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Tamara G. Fong ◽  
Sarinnapha M. Vasunilashorn ◽  
Yun Gou ◽  
Towia A. Libermann ◽  
Simon Dillon ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Older Adults ◽  
Alzheimer's Disease ◽  
Postoperative Delirium ◽  
Disease Biomarkers

scholarly journals Correlation between oligomerizaton of amyloid beta in plasma and other Alzheimer's disease biomarkers

IBRO Reports ◽  
2019 ◽  
Vol 6 ◽  
pp. S91
Author(s):  
Sungmin Kang ◽  
Jeewon Suh ◽  
Jeong Min Pyun ◽  
Young Chul Youn ◽  
Ji Sun Yu ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Amyloid Beta ◽  
Disease Biomarkers

scholarly journals Pre‐analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF

2020 ◽  
Vol 12 (1) ◽  
Author(s):  
Oskar Hansson ◽  
Sandra Rutz ◽  
Henrik Zetterberg ◽  
Ekaterina Bauer ◽  
Teresa Hähl ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Disease Biomarkers ◽  
Analytical Protocol

Cortical circumferential profile of SPECT cerebral perfusion in Alzheimer's disease

1991 ◽  
Vol 40 (3) ◽  
pp. 167-180 ◽  
Author(s):  
Gordon J. Harris ◽  
Jonathan M. Links ◽  
Godfrey D. Pearlson ◽  
Edwaldo E. Camargo
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cerebral Perfusion ◽  
Circumferential Profile

Clinical Characteristic in Primary Progressive Aphasia in Relation to Alzheimer’s Disease Biomarkers

2021 ◽  
pp. 1-13
Author(s):  
Sung Hoon Kang ◽  
Hanna Cho ◽  
Jiho Shin ◽  
Hang-Rai Kim ◽  
Young Noh ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Language Impairment ◽  
Amyloid Β ◽  
Primary Progressive Aphasia ◽  
Cortical Atrophy ◽  
Clinical Feature ◽  
Progressive Aphasia ◽  
Disease Biomarkers ◽  
Primary Progressive

Background: Primary progressive aphasia (PPA) is associated with amyloid-β (Aβ) pathology. However, clinical feature of PPA based on Aβ positivity remains unclear. Objective: We aimed to assess the prevalence of Aβ positivity in patients with PPA and compare the clinical characteristics of patients with Aβ-positive (A+) and Aβ-negative (A–) PPA. Further, we applied Aβ and tau classification system (AT system) in patients with PPA for whom additional information of in vivo tau biomarker was available. Methods: We recruited 110 patients with PPA (41 semantic [svPPA], 27 non-fluent [nfvPPA], 32 logopenic [lvPPA], and 10 unclassified [ucPPA]) who underwent Aβ-PET imaging at multi centers. The extent of language impairment and cortical atrophy were compared between the A+ and A–PPA subgroups using general linear models. Results: The prevalence of Aβ positivity was highest in patients with lvPPA (81.3%), followed by ucPPA (60.0%), nfvPPA (18.5%), and svPPA (9.8%). The A+ PPA subgroup manifested cortical atrophy mainly in the left superior temporal/inferior parietal regions and had lower repetition scores compared to the A–PPA subgroup. Further, we observed that more than 90%(13/14) of the patients with A+ PPA had tau deposition. Conclusion: Our findings will help clinicians understand the patterns of language impairment and cortical atrophy in patients with PPA based on Aβ deposition. Considering that most of the A+ PPA patents are tau positive, understanding the influence of Alzheimer’s disease biomarkers on PPA might provide an opportunity for these patients to participate in clinical trials aimed for treating atypical Alzheimer’s disease.

scholarly journals Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer’s disease and mild cognitive impairment

Brain ◽  
2014 ◽  
Vol 137 (5) ◽  
pp. 1550-1561 ◽  
Author(s):  
Niklas Mattsson ◽  
Duygu Tosun ◽  
Philip S. Insel ◽  
Alix Simonson ◽  
Clifford R Jack ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Cerebral Perfusion ◽  
Amyloid Β
Sign in / Sign up

Export Citation Format

Share Document